Topics

GI Tolerance and Acceptability of a New Thickener

2019-10-01 07:55:03 | BioPortfolio

Summary

The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.

Study Design

Conditions

Gastro-intestinal Tolerance

Intervention

Experimental Thickener

Location

Royal Derby Hospital Centre
Derby
United Kingdom
DE22 3DT

Status

Not yet recruiting

Source

Abbott Nutrition

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-01T07:55:03-0400

Clinical Trials [1082 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Carbohydrates Part 2

The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.

Growth and Tolerance of Infants Fed Milk-Based Infant Formula

The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based i...

Avastin and Tarceva for Upper Gastrointestinal Cancers

Erlotinib and bevacizumab have shown activity individually, as single drugs, or in combination with chemotherapy in upper gastro-intestinal cancers, including esophageal and gastro-esophag...

Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD

Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD) is a complication of allogeneic stem cell transplant which is usually treated with steroids. You are being asked to take part i...

Madrid - Tolerance and Acceptability Study

Tolerance and Acceptability of a gum based thickener.

PubMed Articles [8866 Associated PubMed Articles listed on BioPortfolio]

Incidence of gastro-intestinal anomalies and surgical outcome of fetuses diagnosed with echogenic bowel and bowel dilatation.

We aimed to evaluate the incidence of gastro-intestinal (GI) anomalies and surgical outcome in fetuses diagnosed with either echogenic bowel (EB) or EB plus bowel dilatation (BD) but no associated chr...

Gastro-Intestinal Tract Cancers Following Bariatric Surgery: a Narrative Review.

The association between obesity and malignancies has been identified epidemiologically. Meanwhile, the increasing global number of bariatric surgeries is reported annually; bariatric surgery's effect ...

Co-ingestion of red cabbage with cherry tomato enhances digestive bioaccessibility of anthocyanins but decreases carotenoid bioaccessibility after simulated in vitro gastro-intestinal digestion.

The effects of co-digestion of red cabbage with carrot, baby spinach and/or cherry tomato on the bioaccessibility of anthocyanins and carotenoids such as α-carotene, β-carotene, lutein and lycopene ...

A modified Ester-branched thickener for rheology and wettability during CO fracturing for improved fracturing property.

The thickening performance of CO fracturing fluid was poor because of the low apparent viscosity. In this paper, the thickening performance of a modified silicone on liquid CO is measured, and a rheol...

Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.

Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of allogeneic hematopoietic cell transplantation (allo-HCT) with multisystem involvement. Cases of TMA in the intesti...

Medical and Biotech [MESH] Definitions

Alkylating antineoplastic agent used especially in bladder neoplasms. It is toxic to hair follicles, gastro-intestinal tract, and vasculature.

Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME (see NEURITIS, AUTOIMMUNE, EXPERIMENTAL); MYASTHENIA GRAVIS (see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL); and MULTIPLE SCLEROSIS (see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL).

Groups that serve as a standard for comparison in experimental studies. They are similar in relevant characteristics to the experimental group but do not receive the experimental intervention.

The normal lack of the ability to produce an immunological response to autologous (self) antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognize the difference between self and non-self is the prime function of the immune system.

A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.

More From BioPortfolio on "GI Tolerance and Acceptability of a New Thickener"

Quick Search

Relevant Topics

Abbott
The 11th largest pharmaceutical company in the world, <!--LGfEGNT2Lhm-->Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the <!--LGfEGNT2Lhm-->medical device arm of the company, products of note ar...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Searches Linking to this Trial